• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Organogenesis Holdings Inc. - Class A (NQ:ORGO)

1.740 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.740
Bid (Size) 1.700 (1,700)
Ask (Size) 1.900 (200)
Prev. Close 1.740
Today's Range 1.740 - 1.740
52wk Range 1.540 - 7.077
Shares Outstanding 131,261,833
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Organogenesis (ORGO) Q2 2026 Earnings Call Transcript ↗
August 13, 2026
CMS policy changes drove 58% revenue decline, but sequential recovery signals stabilization. 
Via The Motley Fool
Topics Earnings
What's going on in today's session ↗
August 07, 2026
Via Chartmill

Performance

YTD
-62.5%
-62.5%
1 Month
-31.2%
-31.2%
3 Month
-33.6%
-33.6%
6 Month
-53.0%
-53.0%
1 Year
-64.0%
-64.0%

More News

Read More
Which stocks are gapping on Friday? ↗
August 07, 2026
Via Chartmill
Top movers in Friday's pre-market session ↗
August 07, 2026
Via Chartmill
Organogenesis Holdings (NASDAQ:ORGO) Plunges 17% as Q2 Revenue and EPS Miss Estimates ↗
August 06, 2026
Via Chartmill
Organogenesis Holdings Inc (NASDAQ:ORGO) Soars on Stellar Q4 Earnings Beat ↗
February 26, 2026
Via Chartmill
News headline image
Organogenesis Q2 Earnings Call Highlights ↗
August 07, 2026
Via MarketBeat
Topics Earnings
News headline image
Regenerative Medicine’s Next Chapter: Inside the Race to Make the Body Rebuild Itself
June 18, 2026
From Biotech Insider
Via GlobeNewswire
News headline image
The Quiet Revolution in Regenerative Medicine: From Replacing Tissue to Rebuilding It
June 16, 2026
From World Street Intelligence
Via GlobeNewswire
News headline image
Organogenesis (ORGO) Q1 2026 Earnings Transcript ↗
May 08, 2026
Via The Motley Fool
News headline image
Organogenesis Q1 Earnings Call Highlights ↗
May 08, 2026
Via MarketBeat
Topics Earnings
News headline image
Organogenesis Clears Major FDA Hurdle: Path to First Non-Surgical Biologic for Knee Osteoarthritis Widens
April 13, 2026
Via MarketMinute
News headline image
Organogenesis (ORGO) Q4 2025 Earnings Transcript ↗
February 26, 2026
Via The Motley Fool
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
February 03, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
January 27, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
January 20, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
January 06, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO
December 30, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
Get insights into the top gainers and losers of Monday's after-hours session. ↗
December 15, 2025
Via Chartmill
News headline image
Unusual volume stocks in Monday's session ↗
November 10, 2025
Via Chartmill
News headline image
What's going on in today's session ↗
November 07, 2025
Via Chartmill
News headline image
Keep an eye on the top gainers and losers in Friday's session. ↗
November 07, 2025
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
November 07, 2025
Via Benzinga
News headline image
These stocks are gapping in today's session ↗
November 07, 2025
Via Chartmill

Frequently Asked Questions

Is Organogenesis Holdings Inc. - Class A publicly traded?
Yes, Organogenesis Holdings Inc. - Class A is publicly traded.
What exchange does Organogenesis Holdings Inc. - Class A trade on?
Organogenesis Holdings Inc. - Class A trades on the Nasdaq Stock Market
What is the ticker symbol for Organogenesis Holdings Inc. - Class A?
The ticker symbol for Organogenesis Holdings Inc. - Class A is ORGO on the Nasdaq Stock Market
What is the current price of Organogenesis Holdings Inc. - Class A?
The current price of Organogenesis Holdings Inc. - Class A is 1.740
When was Organogenesis Holdings Inc. - Class A last traded?
The last trade of Organogenesis Holdings Inc. - Class A was at 08/27/26 04:00 PM ET
What is the market capitalization of Organogenesis Holdings Inc. - Class A?
The market capitalization of Organogenesis Holdings Inc. - Class A is 228.40M
How many shares of Organogenesis Holdings Inc. - Class A are outstanding?
Organogenesis Holdings Inc. - Class A has 228M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap